Autopsy report · NCT00721110
Lidocaine and Ketamine in Abdominal Surgery
Cause of deathFutility
“Futility”
Life of this trial
- Ran for about 4 years before it stopped.
- 64 participants enrolled.
- Results were posted on the registry 5 years after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- The Cleveland Clinic
- Sponsor type
- University, hospital or other
- Conditions
- Abdominal Hysterectomy (& Wertheim)
- Interventions
- Lidocaine; Placebo; Ketamine; Ketamine + Lidocaine
- Participants
- 64
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Safety of FMT: OpenBiome Outcomes and Longitudinal Follow-up (STOOL) for Recurrent Clostridium Difficile Infection
“for futility” - The Effectiveness of Non-Pyrethroid Insecticide-Treated Durable Wall Liners as a Method for Malaria Control in Endemic Rural Tanzania
“futility ground” - Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion
“Assessment for futility” - The Use of PrevenaTM on Clean Closed Sternal Midline Incisions in Subjects at High Risk for Surgical Site Occurrences.
“due to futility” - Prevention of Unexplained Recurrent Abortion by Enoxaparine
“Stopped for futility”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.